Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2100 to 2149 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
211.71\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00737\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acrc protein; putative nuclear protein. [source:refseq;acc:nm\_052957]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5a (eif-5a) (eif-4d) (rev- binding factor). [source:swissprot;acc:p10159]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.727\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00736\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transketolase (ec 2.2.1.1) (tk). [source:swissprot;acc:p29401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00731\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymidylate kinase (ec 2.7.4.9) (dtmp kinase). [source:swissprot;acc:p23919]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.328\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.813\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00729\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eif-5a2 protein. [source:refseq;acc:nm\_020390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.591\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.111\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
197.489\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.061\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain only 7; zinc-finger domain-containing protein; lomp protein; f-box only protein 20; f-box protein fbx20. [source:refseq;acc:nm\_005358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.801\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00727\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00726\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran-binding protein 2 (ranbp2) (nuclear pore complex protein nup358) (nucleoporin nup358) (358 kda nucleoporin) (p270). [source:swissprot;acc:p49792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.032\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 6. [source:swissprot;acc:q9y2v7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.099\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00712\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.047\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00706\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases iii 12.5 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c11 subunit) (hsc11p) (hrpc11) (my010 protein). [source:swissprot;acc:q9y2y1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00705\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.533\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.007\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.632\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}}&\multirow{21}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00696\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.911\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shc transforming protein. [source:swissprot;acc:p29353]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 289, id1 regulated; likely ortholog of mouse zfp289. [source:refseq;acc:nm\_032389]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal shc. [source:refseq;acc:nm\_016848]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 1. [source:swissprot;acc:p32889]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a1 (helix-destabilizing protein) (single-strand binding protein) (hnrnp core protein a1). [source:swissprot;acc:p09651]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 3. [source:swissprot;acc:p16587]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp cyclohydrolase i (ec 3.5.4.16) (gtp-ch-i). [source:swissprot;acc:p30793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
226.277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.851\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor hmr (early response protein nak1) (tr3 orphan receptor). [source:swissprot;acc:p22736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.305\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoproteins a2/b1 (hnrnp a2 / hnrnp b1). [source:swissprot;acc:p22626]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear hormone receptor nor-1 (neuron-derived orphan receptor 1) (mitogen induced nuclear orphan receptor). [source:swissprot;acc:q92570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.743\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.308\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ovarian carcinoma immunoreactive antigen. [source:refseq;acc:nm\_017830]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase-activating protein 3 (arf gap 3). [source:swissprot;acc:q9np61]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 2 (sodium-dependent vitamin c transporter 2) (hsvct2) (na(+)/l-ascorbic acid transporter 2) (yolk sac permease-like molecule 2) (nucleobase transporter-like 1 protein). [source:swissprot;acc:q9ugh3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 7 (ec 2.7.1.-) (map kinase kinase 7) (mapkk 7) (mapk/erk kinase 7) (jnk activating kinase 2) (c-jun n-terminal kinase kinase 2) (jnk kinase 2) (jnkk 2). [source:swissprot;acc:o14733]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor, 64 kda subunit (cstf 64 kda subunit) (cf-1 64 kda subunit). [source:swissprot;acc:p33240]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
161.547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
162.665\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nurr1 (immediate-early response protein not) (transcriptionally inducible nuclear receptor). [source:swissprot;acc:p43354]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.343\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein 4.1 (band 4.1) (p4.1) (epb4.1) (4.1r). [source:swissprot;acc:p11171]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.443\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.864\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00688\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.862\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 1 (neuronal protein 4.1) (4.1n). [source:swissprot;acc:q9h4g0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.443\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.864\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 3 (4.1b) (differentially expressed in adenocarcinoma of the lung protein 1) (dal-1). [source:swissprot;acc:q9y2j2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.862\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
band 4.1-like protein 2 (generally expressed protein 4.1) (4.1g). [source:swissprot;acc:o43491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.443\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.864\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
45 kda calcium-binding protein precursor (cab45) (stromal cell-derived factor 4) (sdf-4). [source:swissprot;acc:q9brk5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.442\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.862\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba271b5.1 (similar to ribosomal protein s7). [source:sptrembl;acc:q9h1s9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.871\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.366\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00686\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s7 (s8). [source:swissprot;acc:p23821]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/